Author: user

A look at the day ahead in European and global markets from Stella Qiu 2024 is almost over. Several central banks have concluded their final policy meetings of the year – some held steady and others cut, but all of them were noting a more uncertain 2025 when the global economy and trade could look sharply different with Donald Trump back in the White House. That leaves the U.S. Core Personal Expenditures – the Fed’s preferred gauge of inflation – as the one last hurdle before the usually quiet Christmas time. With upside risks to inflation back on the Fed’s…

Read More

By Samia Nakhoul DUBAI (Reuters) – 2025 will be a year of reckoning for Israeli Prime Minister Benjamin Netanyahu and his country’s arch foe Iran. The veteran Israeli leader is set to cement his strategic goals: tightening his military control over Gaza, thwarting Iran’s nuclear ambitions and capitalising on the dismantling of Tehran’s allies — Palestinian Hamas, Lebanon’s Hezbollah and the removal of Syrian president Bashar al-Assad. Assad’s collapse, the elimination of the top leaders of Hamas and Hezbollah and the destruction of their military structure mark a succession of monumental wins for Netanyahu. Without Syria, the alliances Tehran has…

Read More

(Bloomberg) — Hon Hai Precision Industry Co., the iPhone maker known as Foxconn, is in talks with Nissan Motor Co.’s biggest shareholder Renault SA about its willingness to sell its shares in the Japanese automaker, Taiwan’s Central News Agency said, citing people it didn’t identify. Most Read from Bloomberg Nissan and fellow Japanese carmaker, Honda Motor Co., are exploring a merger, people familiar with the matter said Wednesday, that would create a rival to Toyota Motor Corp. in Japan and better position the combined company to face competitive challenges around the world. One potential spanner in the works however is…

Read More

What is the current outlook for investors in today’s credit market? Interest rates had been in secular decline since the 1980s. In the aftermath of the global financial crisis (GFC), rates hovered near zero as central banks embraced quantitative easing (QE) and flooded markets with liquidity. Among other effects, these monetary policies elevated the valuations of most assets, including private and public debt. This trend came to an end in 2022 when central banks began to raise rates and tighten credit conditions to tame inflation. Today, investors must navigate this transition. In terms of economic expression — and to take…

Read More

SOUTH SAN FRANCISCO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) — Cytokinetics (NASDAQ:), Incorporated  (Nasdaq: CYTK) today announced that Sanofi (NASDAQ:) will acquire exclusive rights to develop and commercialize aficamten from Corxel Pharmaceuticals (CORXEL) for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy (HCM) in Greater China. Aficamten is a next-in-class cardiac myosin inhibitor for the potential treatment of patients with HCM. In 2020, CORXEL (formerly Ji Xing) acquired the rights to develop and commercialize aficamten in Greater China (including the Chinese mainland, Hong Kong SAR and Macau SAR, and Taiwan) from Cytokinetics in accordance with Cytokinetics’ global registration…

Read More

Christopher Hui said the transaction sets a benchmark example for more transactions on HKEX’s Core Climate platform to follow. Subscribe Subscribe to Regulation Asia to gain access to APAC’s leading platform for news, analysis, research and verified data on financial regulation. Select More Information below to view our subscription packages or you can email us at [email protected] to discuss your options. More Information Request a Trial Get in touch today to discuss a trial giving you unrestricted and unlimited access to Regulation Asia for you and/or your team(s) for a limited period. Email us at [email protected] Christopher Hui said the…

Read More

NEW YORK—Saba Capital Management, L.P., a prominent investment firm led by Boaz Weinstein, recently acquired shares of Gabelli Healthcare & WellnessRx Trust (NYSE:GRX). According to a recent SEC filing, Saba Capital purchased 20,408 shares at a price of $9.74 per share, totaling approximately $198,773. This transaction increases their stake to 1,911,034 shares in the $151.37 million market cap trust. The acquisition reflects Saba Capital’s ongoing interest in the healthcare and wellness sector. InvestingPro subscribers can access 5 additional key insights about GRX’s valuation and financial health metrics to better understand this investment move. This article was generated with the support…

Read More

OMAHA, Neb.— Berkshire Hathaway Inc . (NYSE:), led by Warren E. Buffett, has expanded its holdings in Verisign Inc . (NASDAQ:), acquiring a significant amount of shares over a three-day period. According to a recent SEC filing, Berkshire Hathaway purchased a total of 227,113 shares of Verisign’s common stock, amounting to approximately $45.4 million. The technology company, currently valued at $18.62 billion, maintains an impressive gross profit margin of 87.58% and trades at a P/E ratio of 22.5. According to InvestingPro analysis, the stock appears slightly undervalued based on its Fair Value assessment. The transactions occurred between December 17 and…

Read More

New York, New York–(Newsfile Corp. – December 19, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Rentokil Initial plc (NYSE: LON:) between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rentokil ADSs during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Rentokil class action, go to…

Read More

By Market Capitalisation. Net Sales. Net Profit. Total Assets. Excise. Other Income. Raw Materials. Power & Fuel. Employee Cost. PBDIT. Interest. Tax. EPS. Investments. Sundry Debtors. Cash/Bank. Inventory. Debt. Contingent Liabilities. Screen Crit Abrasives Aerospace & Defence Agriculture Air Conditioners Airlines Aluminium & Aluminium Products Amusement Parks/Recreation/Club Aquaculture Auto Ancillaries Auto Ancillaries – Air Conditioning Parts Auto Ancillaries – Auto, Truck & Motorcycle Parts Auto Ancillaries – Axle shafts Auto Ancillaries – Bearings Auto Ancillaries – Brakes Auto Ancillaries – Bus Body Auto Ancillaries – Castings/Forgings Auto Ancillaries – Clutches Auto Ancillaries – Diesel Engines Auto Ancillaries – Engine Parts…

Read More